MedPath

Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye

Phase 4
Completed
Conditions
Dry Eye
Registration Number
NCT00724412
Lead Sponsor
Alcon Research
Brief Summary

Comparison of two Dry Eye products

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
279
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Tear Break-up time42 days
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.